Aura Biosciences, Inc. Profile Avatar - Palmy Investing

Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It deve…

Biotechnology
US, Cambridge [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Institutional
Insider
Retail
77.55%
5.08%
17.37%
Intraday
Shares Outstanding
49,951,466
Volume
121,833
Volume on Avg.
214,278
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $7.56 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of AURA's Analysis
CIK: 1501796 CUSIP: 05153U107 ISIN: US05153U1079 LEI: - UEI: -
Secondary Listings
AURA has no secondary listings inside our databases.